Publication:
Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).

dc.contributor.authorPalao-Ocharan, Paola
dc.contributor.authorPrior, Nieves
dc.contributor.authorPérez-Fernández, Elia
dc.contributor.authorCaminoa, Magdalena
dc.contributor.authorDV-HAE-QoL Study Group
dc.contributor.authorCaballero, Teresa
dc.date.accessioned2023-05-03T13:34:36Z
dc.date.available2023-05-03T13:34:36Z
dc.date.issued2022-03-02
dc.description.abstractThe generic 36-item Short-Form Health Survey (SF-36v2) has been used to assess health related quality of life in adult patients with hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) even though it has not yet been validated for use in this specific disease. This study aims to validate the SF-36v2 for use in adult patients with C1-INH-HAE. There was a very low item non-response rate (1-3.4%), with a high ceiling effect in 25/35 items and a low floor effect in 3/35 items. A moderate ceiling effect was observed in 5/8 dimensions of the SF-36v2, whereas no floor effect was noticed in any of the dimensions. Internal consistency was good to excellent with Cronbach's alpha coefficient ranging between 0.82 and 0.93 for the different dimensions. Construct validity was good: seven out of the 8 hypotheses defined on clinical criteria were confirmed, discriminant validity assessment showed significant differences among patients with different C1-INH-HAE severity, convergent validity showed a good correlation among the physical and mental component summaries of the SF-36v2 and the HAE-QoL total score (0.45 and 0.64 respectively, P  The psychometric properties of the SF-36v2 were evaluated in an international setting based on responses from 290 adult C1-INH-HAE patients in 11 countries.
dc.identifier.doi10.1186/s13023-022-02202-2
dc.identifier.essn1750-1172
dc.identifier.pmcPMC8889710
dc.identifier.pmid35236380
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889710/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1186/s13023-022-02202-2
dc.identifier.urihttp://hdl.handle.net/10668/20338
dc.issue.number1
dc.journal.titleOrphanet journal of rare diseases
dc.journal.titleabbreviationOrphanet J Rare Dis
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.page.number88
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectC1-inhibitor
dc.subjectHAE-QoL
dc.subjectHereditary angioedema
dc.subjectPsychometric study
dc.subjectQuality of life
dc.subjectQuestionnaire
dc.subjectSF-36v2
dc.subject.meshAdult
dc.subject.meshAngioedemas, Hereditary
dc.subject.meshComplement C1 Inhibitor Protein
dc.subject.meshHumans
dc.subject.meshPsychometrics
dc.subject.meshQuality of Life
dc.subject.meshReproducibility of Results
dc.subject.meshSurveys and Questionnaires
dc.titlePsychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number17
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8889710.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format